These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22367657)

  • 21. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
    Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS
    Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W; Shaw J; Bloom M; Gebeline-Myers C
    Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
    Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH
    Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
    Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.
    Falah M; Madsen C; Holbech JV; Sindrup SH
    Eur J Pain; 2012 Jul; 16(6):860-9. PubMed ID: 22337561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
    Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
    J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam is not effective for essential tremor.
    Elble RJ; Lyons KE; Pahwa R
    Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of levetiracetam on essential tremor.
    Bushara KO; Malik T; Exconde RE
    Neurology; 2005 Mar; 64(6):1078-80. PubMed ID: 15781835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific effect of levetiracetam in experimental human pain models.
    Enggaard TP; Klitgaard NA; Sindrup SH
    Eur J Pain; 2006 Apr; 10(3):193-8. PubMed ID: 15946871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
    Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy.
    Fattore C; Boniver C; Capovilla G; Cerminara C; Citterio A; Coppola G; Costa P; Darra F; Vecchi M; Perucca E
    Epilepsia; 2011 Apr; 52(4):802-9. PubMed ID: 21320119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.